ENSG00000127914 |
|
prostate carcinoma |
missense_variant |
3.299% (16/485) |
3 entries |
ENSG00000127914 |
|
colorectal adenocarcinoma |
stop_gained |
9.861% (128/1298) |
3 entries |
ENSG00000127914 |
|
esophageal adenocarcinoma |
missense_variant |
13.01% (57/438) |
2 entries |
ENSG00000127914 |
|
papillary renal cell carcinoma |
stop_gained |
1.194% (4/335) |
1 entry |
ENSG00000127914 |
|
cecum adenocarcinoma |
frameshift_variant |
9.848% (13/132) |
1 entry |
ENSG00000127914 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
9.412% (8/85) |
2 entries |
ENSG00000127914 |
|
prostate adenocarcinoma |
frameshift_variant |
6.121% (89/1454) |
1 entry |
ENSG00000127914 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
2.395% (4/167) |
2 entries |
ENSG00000127914 |
|
Parathyroid Gland Carcinoma |
missense_variant |
15.79% (3/19) |
1 entry |
ENSG00000127914 |
|
Breast Carcinoma by Gene Expression Profile |
missense_variant |
10.53% (2/19) |
2 entries |
ENSG00000127914 |
|
cecum adenocarcinoma |
missense_variant |
9.848% (13/132) |
2 entries |
ENSG00000127914 |
|
prostate adenocarcinoma |
sequence_alteration |
6.121% (89/1454) |
2 entries |
ENSG00000127914 |
|
ovarian serous adenocarcinoma |
missense_variant |
1.189% (8/673) |
2 entries |
ENSG00000127914 |
|
skin melanoma |
missense_variant |
6.722% (65/967) |
5 entries |
ENSG00000127914 |
|
colon adenocarcinoma |
sequence_alteration |
7.403% (57/770) |
3 entries |
ENSG00000127914 |
|
head and neck squamous cell carcinoma |
amino_acid_insertion |
2.236% (14/626) |
1 entry |
ENSG00000127914 |
|
clear cell renal carcinoma |
frameshift_variant |
2.54% (35/1378) |
2 entries |
ENSG00000127914 |
|
colorectal adenocarcinoma |
frameshift_variant |
9.861% (128/1298) |
5 entries |
ENSG00000127914 |
|
bile duct adenocarcinoma |
missense_variant |
1.058% (2/189) |
2 entries |
ENSG00000127914 |
|
small cell lung carcinoma |
missense_variant |
2.469% (8/324) |
1 entry |
ENSG00000127914 |
|
clear cell renal carcinoma |
missense_variant |
2.54% (35/1378) |
4 entries |
ENSG00000127914 |
|
lung adenocarcinoma |
stop_gained |
4.095% (50/1221) |
1 entry |
ENSG00000127914 |
|
brain glioblastoma |
amino_acid_insertion |
0.9719% (9/926) |
1 entry |
ENSG00000127914 |
|
basal cell carcinoma |
missense_variant |
8.621% (5/58) |
1 entry |
ENSG00000127914 |
|
colon adenocarcinoma |
stop_gained |
7.403% (57/770) |
3 entries |
ENSG00000127914 |
|
female breast carcinoma |
missense_variant |
1.79% (7/391) |
2 entries |
ENSG00000127914 |
|
HER2 Positive Breast Carcinoma |
missense_variant |
7.104% (13/183) |
2 entries |
ENSG00000127914 |
|
clear cell renal carcinoma |
sequence_alteration |
2.54% (35/1378) |
2 entries |
ENSG00000127914 |
|
bladder transitional cell carcinoma |
missense_variant |
2.19% (3/137) |
1 entry |
ENSG00000127914 |
|
melanoma |
frameshift_variant |
11.88% (12/101) |
1 entry |
ENSG00000127914 |
|
Cervical Small Cell Carcinoma |
missense_variant |
33.33% (2/6) |
1 entry |
ENSG00000127914 |
|
melanoma |
stop_gained |
11.88% (12/101) |
1 entry |
ENSG00000127914 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
9.412% (8/85) |
1 entry |
ENSG00000127914 |
|
cecum adenocarcinoma |
stop_gained |
9.848% (13/132) |
1 entry |
ENSG00000127914 |
|
lung adenocarcinoma |
missense_variant |
4.095% (50/1221) |
7 entries |
ENSG00000127914 |
|
colon adenocarcinoma |
frameshift_variant |
7.403% (57/770) |
4 entries |
ENSG00000127914 |
|
breast ductal adenocarcinoma |
sequence_alteration |
13.78% (85/617) |
2 entries |
ENSG00000127914 |
|
breast carcinoma |
missense_variant |
1.983% (28/1412) |
3 entries |
ENSG00000127914 |
|
lung adenocarcinoma |
sequence_alteration |
4.095% (50/1221) |
2 entries |
ENSG00000127914 |
|
prostate carcinoma |
frameshift_variant |
3.299% (16/485) |
2 entries |
ENSG00000127914 |
|
papillary renal cell carcinoma |
missense_variant |
1.194% (4/335) |
1 entry |
ENSG00000127914 |
|
small cell lung carcinoma |
frameshift_variant |
2.469% (8/324) |
2 entries |
ENSG00000127914 |
|
esophageal adenocarcinoma |
frameshift_variant |
13.01% (57/438) |
1 entry |
ENSG00000127914 |
|
melanoma |
sequence_alteration |
11.88% (12/101) |
1 entry |
ENSG00000127914 |
|
gastric adenocarcinoma |
missense_variant |
4.418% (30/679) |
2 entries |
ENSG00000127914 |
|
prostate adenocarcinoma |
missense_variant |
6.121% (89/1454) |
3 entries |
ENSG00000127914 |
|
skin melanoma |
stop_gained |
6.722% (65/967) |
1 entry |
ENSG00000127914 |
|
melanoma |
missense_variant |
11.88% (12/101) |
1 entry |
ENSG00000127914 |
|
colorectal adenocarcinoma |
conservative_inframe_deletion |
9.861% (128/1298) |
2 entries |
ENSG00000127914 |
|
colorectal adenocarcinoma |
sequence_alteration |
9.861% (128/1298) |
4 entries |
ENSG00000127914 |
|
colon adenocarcinoma |
missense_variant |
7.403% (57/770) |
8 entries |
ENSG00000127914 |
|
hepatocellular carcinoma |
missense_variant |
2.32% (21/905) |
1 entry |
ENSG00000127914 |
|
central nervous system primitive neuroectodermal neoplasm |
missense_variant |
2.477% (11/444) |
2 entries |
ENSG00000127914 |
|
squamous cell lung carcinoma |
sequence_alteration |
3.152% (26/825) |
1 entry |
ENSG00000127914 |
|
gastric adenocarcinoma |
stop_gained |
4.418% (30/679) |
1 entry |
ENSG00000127914 |
|
Thyroid Gland Oncocytic Follicular Carcinoma |
gene_fusion |
47.5% (19/40) |
1 entry |
ENSG00000127914 |
|
oral squamous cell carcinoma |
missense_variant |
4.762% (10/210) |
4 entries |
ENSG00000127914 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
5.242% (66/1259) |
2 entries |
ENSG00000127914 |
|
breast ductal adenocarcinoma |
missense_variant |
13.78% (85/617) |
2 entries |
ENSG00000127914 |
|
squamous cell lung carcinoma |
missense_variant |
3.152% (26/825) |
4 entries |
ENSG00000127914 |
|
prostate carcinoma |
sequence_alteration |
3.299% (16/485) |
1 entry |
ENSG00000127914 |
|
alveolar rhabdomyosarcoma |
missense_variant |
3.39% (2/59) |
1 entry |
ENSG00000127914 |
|
diffuse large B-cell lymphoma |
missense_variant |
1.967% (6/305) |
3 entries |
ENSG00000127914 |
|
colorectal adenocarcinoma |
missense_variant |
9.861% (128/1298) |
6 entries |
ENSG00000127914 |
|
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
6.534% (36/551) |
1 entry |
ENSG00000127914 |
|
metaplastic breast carcinoma |
missense_variant |
3.922% (2/51) |
1 entry |
ENSG00000127914 |
|
brain glioblastoma |
missense_variant |
0.9719% (9/926) |
1 entry |
ENSG00000127914 |
|
rectal adenocarcinoma |
missense_variant |
3.493% (8/229) |
4 entries |
ENSG00000127914 |
|
papillary thyroid carcinoma |
gene_fusion |
49.81% (265/532) |
2 entries |
ENSG00000127914 |
|
endometrial carcinoma |
missense_variant |
8.696% (2/23) |
2 entries |
ENSG00000127914 |
|
esophageal squamous cell carcinoma |
missense_variant |
3.102% (21/677) |
6 entries |
ENSG00000127914 |
|
esophageal adenocarcinoma |
sequence_alteration |
13.01% (57/438) |
1 entry |
ENSG00000127914 |
|
head and neck squamous cell carcinoma |
sequence_alteration |
2.236% (14/626) |
1 entry |
ENSG00000127914 |
|
hemangioblastoma |
frameshift_variant |
10.0% (1/10) |
1 entry |
ENSG00000127914 |
|
neoplasm |
missense_variant |
10.71% (3/28) |
1 entry |
ENSG00000127914 |
|
pseudomyxoma peritonei |
stop_gained |
10.0% (1/10) |
1 entry |
ENSG00000127914 |
|
small cell lung carcinoma |
sequence_alteration |
2.469% (8/324) |
1 entry |
ENSG00000127914 |
|
lung carcinoid tumor |
missense_variant |
9.091% (1/11) |
1 entry |
ENSG00000127914 |
|
colorectal adenocarcinoma |
amino_acid_insertion |
9.861% (128/1298) |
1 entry |
ENSG00000127914 |
|
diffuse large B-cell lymphoma |
stop_gained |
1.967% (6/305) |
1 entry |
ENSG00000127914 |
|
female breast carcinoma |
conservative_inframe_deletion |
1.79% (7/391) |
1 entry |
ENSG00000127914 |
|
T-cell acute lymphoblastic leukemia |
stop_gained |
0.2632% (1/380) |
1 entry |
ENSG00000127914 |
|
Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000127914 |
|
non-small cell lung carcinoma |
missense_variant |
1.613% (1/62) |
1 entry |
ENSG00000127914 |
|
Parathyroid Gland Carcinoma |
stop_gained |
15.79% (3/19) |
1 entry |
ENSG00000127914 |
|
brain glioblastoma |
frameshift_variant |
0.9719% (9/926) |
1 entry |
ENSG00000127914 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
1.786% (2/112) |
1 entry |
ENSG00000127914 |
|
basal cell carcinoma |
sequence_alteration |
8.621% (5/58) |
1 entry |
ENSG00000127914 |
|
polycythemia vera |
missense_variant |
2.083% (1/48) |
1 entry |
ENSG00000127914 |
|
Merkel cell skin cancer |
missense_variant |
6.667% (2/30) |
1 entry |
ENSG00000127914 |
|
gastric adenocarcinoma |
frameshift_variant |
4.418% (30/679) |
1 entry |
ENSG00000127914 |
|
Gallbladder Adenocarcinoma |
missense_variant |
1.786% (2/112) |
1 entry |
ENSG00000127914 |
|
breast ductal adenocarcinoma |
frameshift_variant |
13.78% (85/617) |
1 entry |
ENSG00000127914 |
|
ovarian serous adenocarcinoma |
amino_acid_insertion |
1.189% (8/673) |
1 entry |
ENSG00000127914 |
|
Ampulla of Vater Carcinoma |
missense_variant |
1.176% (1/85) |
1 entry |
ENSG00000127914 |
|
Merkel cell skin cancer |
sequence_alteration |
6.667% (2/30) |
1 entry |
ENSG00000127914 |
|
rectal adenocarcinoma |
stop_gained |
3.493% (8/229) |
1 entry |
ENSG00000127914 |
|
colon carcinoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000127914 |
|
head and neck squamous cell carcinoma |
missense_variant |
2.236% (14/626) |
1 entry |
ENSG00000127914 |
|
adenosquamous lung carcinoma |
missense_variant |
18.18% (2/11) |
1 entry |
ENSG00000127914 |
|
adenosquamous lung carcinoma |
stop_gained |
18.18% (2/11) |
1 entry |
ENSG00000127914 |
|
gastric intestinal type adenocarcinoma |
stop_gained |
9.412% (8/85) |
1 entry |
ENSG00000127914 |
|
oral squamous cell carcinoma |
stop_gained |
4.762% (10/210) |
1 entry |
ENSG00000127914 |
|
large cell lung carcinoma |
missense_variant |
5.556% (1/18) |
1 entry |
ENSG00000127914 |
|
chondrosarcoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000127914 |
|
diffuse gastric adenocarcinoma |
missense_variant |
1.266% (1/79) |
1 entry |
ENSG00000127914 |
|
meningioma (disease) |
missense_variant |
2.041% (1/49) |
1 entry |
ENSG00000127914 |
|
ovarian serous adenocarcinoma |
stop_gained |
1.189% (8/673) |
1 entry |
ENSG00000127914 |
|
rectal adenocarcinoma |
sequence_alteration |
3.493% (8/229) |
1 entry |
ENSG00000127914 |
|
chromophobe renal cell carcinoma |
frameshift_variant |
0.8696% (1/115) |
1 entry |
ENSG00000127914 |
|
skin carcinoma |
stop_gained |
4.808% (5/104) |
1 entry |
ENSG00000127914 |
|
Pleural Epithelioid Mesothelioma |
frameshift_variant |
2.128% (2/94) |
1 entry |
ENSG00000127914 |
|
Pleural Epithelioid Mesothelioma |
amino_acid_insertion |
2.128% (2/94) |
1 entry |
ENSG00000127914 |
|
Invasive Breast Carcinoma |
missense_variant |
2.174% (1/46) |
1 entry |
ENSG00000127914 |
|
ovarian neoplasm |
missense_variant |
1.724% (1/58) |
1 entry |